Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Kawaguchi, Koji ^a   Sato, Kengo ^b   Horie, Akihisa ^a   Iketani, Susumu ^c   Yamada, Hiroyuki ^a   Nakatani, Yasunori ^c   Sato, Junichi ^a   Hamada, Yoshiki ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b Yokohama CyberKnife Center   (Japan)

^c Toshiba Rinkan Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MALE; RADIATION DOSE FRACTIONATION; REPEATED DRUG DOSE; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME; TASTE DISORDER; THERAPY EFFECT; TREATMENT RESPONSE; TUMOR BIOPSY; XEROSTOMIA; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIOSURGERY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953219427     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-51     Document Type: Article

References (31)

1. Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 2008, 123:2390-2396. 10.1002/ijc.23798, 18729183.
2. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001, 345:1890-1900. 10.1056/NEJMra001375, 11756581.
3. Licitra L, Vermorken JB. Is there still a role for neoadjuvant chemotherapy in head and neck cancer?. Ann Oncol 2004, 15:7-11. 10.1093/annonc/mdh001, 14679112.
4. De Crevoisier R, Bourhis J, Eschwege F. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas. Cancer Treat Res 2003, 114:199-212. full_text, 12619542.
5. Kramer NM, Horwitz EM, Cheng J, et al. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 2005, 27:406-414. 10.1002/hed.20163, 15719391.
6. Spencer S, Wheeler R, Peters G, et al. Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer. Head Neck 2003, 25:118-122. 10.1002/hed.10178, 12509794.
7. Oksuz DC, Meral G, Uzel O, Cagatay P, Turkan S. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2004, 60:388-394.
8. Yu KH, Leung SF, Tung SY, et al. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck 2005, 27:397-405. 10.1002/hed.20161, 15726589.
9. Tate DJ, Adler JR, Chang SD, et al. Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiat Oncol Biol Phys 1999, 45:915-921.
10. Kawaguchi K, Yamada H, Horie A, Sato K. Radiosurgical treatment of maxillary squamous cell carcinoma. Int J Oral Maxillofac Surg 2009, 38:1205-1207. 10.1016/j.ijom.2009.06.003, 19577433.
11. Pai PC, Chuang CC, Wei KC, et al. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck 2002, 24:748-753. 10.1002/hed.10116, 12203799.
12. Low JS, Chua ET, Gao F, Wee JT. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma. Head Neck 2006, 28:321-329. 10.1002/hed.20338, 16287135.
13. Voynov G, Heron DE, Burton S, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 2006, 5:529-535.
14. Roh KW, Jang JS, Kim MS, et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009, 74:1348-1355.
15. Heron DE, Ferris RL, Karamouzis M, et al. Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of a Phase I Dose-Escalation Trial. Int J Radiat Oncol Biol Phys 2009,
16. Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003, 56:1046-1054. 10.1016/S0360-3016(03)00117-2, 12829140.
17. Jansen EP, Keus RB, Hilgers FJ, et al. Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma?. Int J Radiat Oncol Biol Phys 2000, 48:27-35. 10.1016/S0360-3016(00)00594-0, 10924968.
18. Fu D, Kuduvalli G. A fast, accurate, and automatic 2D-3D image registration for image-guided cranial radiosurgery. Med Phys 2008, 35:2180-2194. 10.1118/1.2903431, 18561693.
19. Antypas C, Pantelis E. Performance evaluation of a CyberKnife G4 image-guided robotic stereotactic radiosurgery system. Phys Med Biol 2008, 53:4697-4718. 10.1088/0031-9155/53/17/016, 18695294.
20. Romanelli P, Schaal DW, Adler JR. Image-guided radiosurgical ablation of intra- and extra-cranial lesions. Technol Cancer Res Treat 2006, 5:421-428.
21. Hara W, Soltys SG, Gibbs IC. CyberKnife robotic radiosurgery system for tumor treatment. Expert Rev Anticancer Ther 2007, 7:1507-1515. 10.1586/14737140.7.11.1507, 18020920.
22. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216. 10.1093/jnci/92.3.205, 10655437.
23. Rwigema JC, Heron DE, Ferris RL, et al. Fractionated Stereotactic Body Radiation Therapy in the Treatment of Previously-Irradiated Recurrent Head and Neck Carcinoma: Updated Report of the University of Pittsburgh Experience. Am J Clin Oncol 2009,
24. Unger KR, Lominska CE, Deeken JF, et al. Fractionated Stereotactic Radiosurgery for Reirradiation of Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys 2010,
25. Siddiqui F, Patel M, Khan M, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 2009, 74:1047-1053.
26. Agulnik M, Epstein JB. Nasopharyngeal carcinoma: current management, future directions and dental implications. Oral Oncol 2008, 44:617-627. 10.1016/j.oraloncology.2007.08.003, 18061518.
27. Tsukuda M, Kida A, Fujii M, et al. [Long-term results of S-1 administration as adjuvant chemotherapy for advanced head and neck cancer]. Gan To Kagaku Ryoho 2007, 34:1215-1225.
28. Yamashita T, Shinden S, Watabe T, Shiotani A. Outpatient chemotherapy with S-1 for recurrent head and neck cancer. Anticancer Res 2009, 29:577-581.
29. Suzuki S, Ishikawa K. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer. J Infect Chemother 2009, 15:335-339. 10.1007/s10156-009-0712-x, 19856075.
30. Kawasaki M, Watanabe K, Watanabe J. [TS-1 and irradiation combination therapy for head and neck cancer]. Gan To Kagaku Ryoho 2006, 33:1077-1080.
31. Sulman EP, Schwartz DL, Le TT, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009, 73:399-409.